These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 11160483)
1. Diagnosis of a multifocal B cell lymphoma with preceding demyelinating central nervous system lesions by single voxel proton MR spectroscopy. Kuhlmann T; Schröter A; Dechent P; Weber F; Rustenbeck HH; Füzesi L; Brück W; Ehrenreich H; Frahm J J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):259-62. PubMed ID: 11160483 [TBL] [Abstract][Full Text] [Related]
2. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Thomas PK; Walker RW; Rudge P; Morgan-Hughes JA; King RH; Jacobs JM; Mills KR; Ormerod IE; Murray NM; McDonald WI Brain; 1987 Feb; 110 ( Pt 1)():53-76. PubMed ID: 3026554 [TBL] [Abstract][Full Text] [Related]
3. [Demyelinating pseudotumoral lesion prior to a primary cerebral lymphoma]. Alarcia R; Ara JR; Marta E; Barrena MR; Giménez-Más JA; Capablo JL; Serrano M Rev Neurol; 2000 Nov 16-30; 31(10):955-8. PubMed ID: 11244691 [TBL] [Abstract][Full Text] [Related]
4. Rapid proton fat-water spectroscopy for the characterization of non-CNS lesions in vivo. Riedy G Clin Imaging; 2003; 27(3):145-9. PubMed ID: 12727049 [TBL] [Abstract][Full Text] [Related]
5. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. Zacharia TT; Law M; Naidich TP; Leeds NE J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774 [TBL] [Abstract][Full Text] [Related]
6. The nonspecific nature of proton spectroscopy in brain masses in children: a series of demyelinating lesions. Pandya HG; Wilkinson ID; Agarwal SK; Griffiths PD Neuroradiology; 2005 Dec; 47(12):955-9. PubMed ID: 15776226 [TBL] [Abstract][Full Text] [Related]
7. [Proton MR spectroscopy (1H-MRS): clinical usefulness for MR diagnosis of central nervous system]. Ida M; Nakamura K; Arai T; Tokuyama T; Onishi T No To Shinkei; 2002 Nov; 54(11):935-41. PubMed ID: 12512118 [No Abstract] [Full Text] [Related]
8. Proton magnetic resonance spectroscopy and magnetic resonance imaging findings in a patient with central nervous system paracoccidioidomycosis. Faria AV; Dabus GC; Zanardi VA; Cendes F J Neuroimaging; 2004 Oct; 14(4):377-9. PubMed ID: 15358962 [TBL] [Abstract][Full Text] [Related]
9. Nuclear magnetic resonance imaging in central nervous system disease. Buonanno FS; Kistler JP; DeWitt LD; Davis KR; DeLaPaz R; New PF; Burt CT; Brady TJ Semin Nucl Med; 1983 Oct; 13(4):329-38. PubMed ID: 6648538 [TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of the central nervous system. Norman D; Brant-Zawadzki M Res Publ Assoc Res Nerv Ment Dis; 1985; 63():259-69. PubMed ID: 4023403 [TBL] [Abstract][Full Text] [Related]
11. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions. Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073 [TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. Silver NC; Barker RA; MacManus DG; Barker GJ; Thom M; Thomas DG; McDonald WI; Miller DH J Neurol; 1997 Mar; 244(3):204-7. PubMed ID: 9050963 [No Abstract] [Full Text] [Related]
13. Magnetic resonance imaging of the central nervous system. Bradley WG Neurol Res; 1984 Sep; 6(3):91-106. PubMed ID: 6151140 [TBL] [Abstract][Full Text] [Related]
14. [NMR: basic and clinical researches in diagnosis of CNS lesions]. Yamaura A No To Shinkei; 1985 May; 37(5):433-43. PubMed ID: 2992554 [No Abstract] [Full Text] [Related]
15. [Tumor-like inflammatory demyelinating diseases of the central nervous system with relapse onset: a case report and review]. Qi XL; Chen J; Zheng RL; Li Y; Huang YN; Yuan Y Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):588-9. PubMed ID: 19829680 [TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas. Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108 [TBL] [Abstract][Full Text] [Related]
17. [Demyelinating disease affecting both central and peripheral nervous system]. Carra-Dallière C; Mania A; Carlander B; Camu W; Juntas-Morales R Rev Neurol (Paris); 2011 Dec; 167(12):921-5. PubMed ID: 21596409 [TBL] [Abstract][Full Text] [Related]
18. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924 [TBL] [Abstract][Full Text] [Related]
20. Neuroimaging in postinfectious demyelination and nutritional disorders of the central nervous system. Lim CC Neuroimaging Clin N Am; 2011 Nov; 21(4):843-58, viii. PubMed ID: 22032502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]